2016 Press Releases

Keyword Search
 
2017 | 2016 | 2015 | 2014 | 2013 | 2012
Auris Medical on Track to Resume Enrollment of Keyzilen Tinnitus Program Following Regulatory Feedback
06 December 2016
Auris Medical Provides Business Update and Reports Third Quarter 2016 Financial Results
10 November 2016
Auris Medical to Announce Third Quarter 2016 Financial Results and Host Conference Call on Thursday, November 10, 2016
03 November 2016
Auris Medical Provides Update on Development of Keyzilen for the Treatment of Acute Inner Ear Tinnitus
11 October 2016
Auris Medical to Announce Keyzilen Program Update and Host Conference Call and Webcast Tomorrow, October 11, 2016
10 October 2016
Auris Medical Announces AAO-HNSF Annual Meeting Activities
13 September 2016
Auris Medical Achieves Midpoint for Enrollment in Phase 3 Trial of AM-111 in Sudden Deafness
09 September 2016
Auris Medical Provides Business Update and Reports Second Quarter 2016 Financial Results
18 August 2016
Auris Medical Reports Top-Line Results from TACTT2 Trial with Keyzilen in Acute Inner Ear Tinnitus
18 August 2016
Auris Medical to Announce Second Quarter 2016 Financial Results and Host Conference Call and Webcast on Thursday, August 18, 2016
16 August 2016
Auris Medical Secures Loan Facility of Up To $20 Million
19 July 2016
FDA Grants Auris Medical Fast Track Designation for Keyzilen in Acute Peripheral Tinnitus
18 July 2016
Auris Medical to Present at Cantor Fitzgerald's 2nd Annual Healthcare Conference on Tuesday, July 12
08 July 2016
Auris Medical Completes Enrollment of Phase 3 TACTT3 Trial with Keyzilen in Acute and Post-Acute Inner Ear Tinnitus
28 June 2016
Auris Medical Initiates ASSENT Phase 3 Trial of AM-111 for Treatment of Sudden Deafness
17 June 2016
Auris Medical to Present at the JMP Securities Life Sciences Conference on Wednesday, June 22
16 June 2016
Auris Medical Hosts Key Opinion Leader Event Focused on Phase 3 Program for Acute Inner Ear Tinnitus
14 June 2016
Auris Medical to Host Key Opinion Leader Event Focused on Acute Inner Ear Tinnitus and AM-101's Phase 3 Program on June 14 in New York City
07 June 2016
Auris Medical to Present at the Jefferies 2016 Healthcare Conference on Thursday, June 9
02 June 2016
Auris Medical Provides Business Update and Reports First Quarter 2016 Financial Results
11 May 2016
Auris Medical to Announce First Quarter 2016 Financial Results and Host Conference Call on Wednesday, May 11, 2016
04 May 2016
Auris Medical to Present at the 15th Annual Needham Healthcare Conference on Tuesday, April 12
05 April 2016
Auris Medical Completes Enrollment of TACTT2 Phase 3 Trial of AM-101 in Acute Inner Ear Tinnitus
30 March 2016
Auris Medical Provides Business Update and Reports Fourth Quarter and Full Year 2015 Financial Results
14 March 2016
Auris Medical to Announce Fourth Quarter and Full Year 2015 Financial Results and Host Conference Call on Monday, March 14, 2016
02 March 2016
Auris Medical to Host Key Opinion Leader Meeting and Webcast Focused on Acute Sensorineural Hearing Loss on February 26 in New York City
18 February 2016
Auris Medical to Present at the 2016 Leerink Global Healthcare Conference on Thursday, February 11
05 February 2016